HMI-202: Gene Therapy Development Candidate for Metachromatic Leukodystrophy (MLD)

HMI-202: Gene Therapy Development Candidate for Metachromatic Leukodystrophy (MLD)

Gingras J, St-Martin T, Gall K, et al.